Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Timothy A. Johnson Medical Scholar Lecture presented by the Fralin Biomedical Research Institute at VTC and the Virginia Tech Carilion School of Medicine
Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Date: Nov. 6, 2020
Time: 1:00 p.m. - 2:00 p.m.
Talk Abstract
Dr. Sheehan will describe her career as a physician scientist, and how her laboratory uses genomics to unravel the mechanisms of globin switching and the pharmacogenomics of hydroxyurea in SCD, in order to develop new fetal hemoglobin inducing agents to treat people with sickle cell disease. Her work has led to a clinical trial of metformin as a fetal hemoglobin inducing agent in patients with hemoglobinopathies. Dr. Sheehan has also developed rheology biomarkers for use in assessing cure in gene based therapy, and collaborates with Dr. Gang Bao to assess the safety and efficacy of CRISPR /Cas9 based gene therapy in SCD.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and the Virginia Tech Carilion School of Medicine. The Timothy A. Johnson Medical Scholar Lecture Series hosts clinician scientists who are exploring frontiers of medicine. These lectures are principally intended for Virginia Tech Carilion School of Medicine students and Virginia Tech students in Translational Biology, Medicine, and Health graduate program. Virginia Tech and Carilion Clinic faculty, staff, and students may also attend.
You May Also Be Interested In...
-
Home Item
Inheriting Chromatin Domains in Mammals and the Mechanisms Involved , homeSept. 5, 2025, 11:00 a.m. | Thelma Escobar, Ph.D., Assistant Professor, Department of Biochemistry, Institute for Stem Cell & Regenerative Medicine, University of Washington | Co-Sponsored by the Fralin Biomedical Research Institute and Cancer Research Center — D.C.
-
Home Item
Flow Induced Endothelial Planar Polarity for Signaling Regulation , homeSept. 19, 2025, 11:00 a.m. | Julia Mack, Ph.D., Assistant Adjunct Professor, David Geffen School of Medicine, Division of Cardiology, University of California Los Angeles | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Maury Strauss Distinguished Public Lecture , homeSept. 18, 2025, 5:30 p.m. (Reception at 5 p.m.) | Robert Gourdie, Ph.D., FAHA, AIMBE, Heywood Fralin Professor and Director, Center for Vascular and Heart Research, Fralin Biomedical Research Institute; Professor, Department of Biomedical Engineering and Mechanics, Virginia Tech College of Engineering; Elected Member, National Academy of Inventors | Maury Strauss Distinguished Public Lecture
-
Home Item
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , homeOct. 3, 2025, 11:00 a.m. | Paule Valery Joseph, Ph.D., Lasker Clinical Research Scholar, NIH Distinguished Scholar; Acting Chief, Section of Sensory Science and Metabolism Unit, Co-Director of the National Smell and Taste Center, National Institute on Deafness and Other Communication Disorders; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home Item
Organization and Control of Hippocampal Networks , homeOct. 17, 2025, 11:00 a.m. | Ivan Soltesz, Ph.D., James R. Doty Professor of Neurosurgery and Neurosciences, Stanford University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
Vivien Sheehan, M.D., Ph.D.
Associate Professor of Pediatrics, and Director of Translational Sickle Cell Disease Research at the Emory University School of Medicine